Full-Time

Quality Control Analyst 3

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

Compensation Overview

$84k - $104k/yr

+ 401(k) match + Relocation assistance

Rensselaer, NY, USA

In Person

Relocation assistance is available.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
ISO 9001

Get referred to Curia

See people who can refer or advise you

Requirements
  • Bachelor's degree in Chemistry or a related field.
  • Minimum 5-7 years of pharmaceutical experience or an equivalent combination of education and experience.
  • Ability to meet deadlines and work under pressure with limited supervision.
  • Strong time management and organizational skills, with the ability to multitask and manage multiple projects independently.
  • Ability to read, analyze, and interpret general business periodicals, professional journals, technical procedures, or governmental regulations.
  • Ability to write reports, business correspondence, and procedure manuals.
  • Ability to apply advanced mathematical concepts such as exponents, logarithms, quadratic equations, and permutations.
  • Ability to apply mathematical operations to frequency distribution, test reliability and validity, analysis of variance, correlation techniques, sampling theory, and factor analysis.
  • Ability to define problems, collect data, establish facts, and draw valid conclusions.
  • Ability to interpret technical instructions in mathematical or diagram form and deal with abstract and concrete variables.
  • Proficient use of Microsoft Office Suite and instrument manufacturer-based systems.
  • Knowledge of FDA good manufacturing practices, including 21 CFR Parts 211, 820, and/or 600.
Responsibilities
  • Perform complex testing and data evaluation, including thermogravimetric analysis.
  • Perform complex liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and other testing; troubleshoot issues as needed.
  • Participate in or assist with test method validations.
  • Evaluate data for trends.
  • Support supervisors in out-of-specification investigations and complete corrective and preventive action requirements.
  • Interact with outside departments, including attending meetings and providing updates.
  • Coordinate testing performed at outside testing laboratories and testing of raw materials.
  • Maintain detailed and accurate records of activities and results.
  • Execute, author, and review standard operating procedures, reports, protocols, investigations, change controls, and data summaries.
  • Understand and use basic risk-assessment and root-cause tools.
  • Train on and understand methods, equipment, and standard operating procedures.
  • Provide training to others as needed and attend internal and external training on related subjects.
  • Support equipment upkeep and laboratory method troubleshooting.
  • Provide technical assistance during the shift for test-method troubleshooting.
  • Prepare and order supplies as necessary.
  • Enter data into relevant data-management systems; track and trend data, compile data, and provide summaries to management.
  • Apply regulatory and compliance guidelines for the pharmaceutical industry.
  • Interact with other company departments regarding testing needs and scheduling.
  • Lead departmental projects and participate in or lead cross-functional teams, including continuous-improvement projects and new-customer teams, as assigned.
  • Lead stability programs, including managing test points, reporting data, and investigating out-of-specification or aberrant stability results, as assigned.
Desired Qualifications
  • Experience working in a current good manufacturing practice or good laboratory practice pharmaceutical-industry environment.
  • Knowledge of ISO 9001 and ISO 13485.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.